 ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, will report unaudited financial results for the quarter ended March 31, 2020 after the market closes on Wednesday, May 13, 2020. The Company has scheduled a conference call the next morning, Thursday, May 14, 2020, at 9:00 AM ET to review the results. Interested parties can access the conference call scheduled by the Company to review these results by dialing 844 855-9502 toll free or 412 317-5499 international at 9:00 AM ET on Thursday, May 14, 2020. 